Transcranial Pulse Stimulation (TPS) continues to advance as a promising non-invasive neuromodulation technique in neuroscience. With growing evidence of therapeutic benefits in Alzheimer’s disease — including improvements in memory, mood, and cognition — research is increasingly focused on uncovering the underlying...
Shock wave therapy in sports medicine: international experts present new guidelines
According to the World Health Organization (WHO), musculoskeletal conditions affect more than 1.7 billion people worldwide.1 Extracorporeal Shock Wave Therapy (ESWT) can treat such conditions and has gained popularity in sports medicine, but experts remain divided on its optimal use, efficacy,...
Focus on shock wave therapy for acute and chronic wounds
Despite the advanced treatment options available, chronic wounds continue to pose a challenge in therapy. They often heal only incompletely and are susceptible to infection. Against this background, Extracorporeal Shock Wave Therapy (ESWT) has increasingly formed the focus of research. A new...
Milestone: Study protocol for the first TPS-Parkinson’s trial in the USA published
Parkinson's disease is not only the second most prevalent neurodegenerative disease after Alzheimer's disease, but also the fastest growing. With the number of cases steadily increasing, there is an urgent need for innovative therapeutic approaches. Scientists at the world-renowned Spaulding Rehabilitation...
Alzheimer and TPS: New data suggest positive effects of non-invasive brain stimulation
Alzheimer’s disease (AD) continues to pose one of the greatest challenges in medicine, with progressive cognitive decline and limited treatment options. A recently published study by Cont et al., under the lead of Prof. Lars Wojtecki, explores the potential of Transcranial...
Evidence-Based, Non-Invasive Stone Therapy (SWL) With High Success Rates – MODULITH® SLK »inline«
The field of urolithiasis treatment continues to evolve rapidly, balancing technological innovation with clinical outcomes and patient-centered care. Among available options, Shock Wave Lithotripsy (SWL) remains the only non-invasive treatment modality. Prof. Kemal Sarica, a globally recognised long-time advocate for SWL,...
STORZ MEDICAL Becomes Top Partner of ratiopharm ulm
Innovative Technologies Meet Top-Level Sports Performance. We are proud to announce our newest partnership with ratiopharm ulm, one of Germany’s most celebrated basketball clubs. This collaboration marks a significant milestone in STORZ MEDICAL’s commitment to elite sports and sports medicine. As...
New review article: The Potential of Brain Stimulation Techniques in Alzheimer’s Disease
Alzheimer’s disease (AD) is clinically characterized by progressive cognitive decline, affecting memory, language, orientation, and behaviour. Neural oscillations, also known as brain waves, are integral to cognitive processes but become dysregulated in AD, contributing to network dysfunction and memory impairments. Targeting...
STORZ MEDICAL behind the scenes at the FIS Snowboard, Freestyle and Freeski World Championships 2025
STORZ MEDICAL was on hand at this year’s Snowboard, Freestyle and Freeski World Championships in Engadin – with proven medical technology to support international elite athletes. From 17 to 30 March 2025, medals were contested at the highest level at venues...
Alzheimer’s patient expresses his gratitude with a historic Panneau Japonais
C. L. looks back on an exciting career. The former French wrestler from Ribeauvillé in Alsace, France became European wrestling champion in 1977, won races as a cyclist, and worked in Germany as a documentary filmmaker and photographer. But C. L....
Welcome to the new »my Storz MEDICAL« portal – your exclusive access to expertise and service
With the successful launch of our new »my STORZ MEDICAL« customer portal, we are offering our customers improved, more direct and more efficient access to key information, exclusive services, and specialist expertise. But what exactly does this mean for you as...
More space for growth and attractive workplaces: New administration building and warehouse completed
A new administration building and an additional warehouse have been constructed at STORZ MEDICAL's headquarters in Tägerwilen on the Swiss side of Lake Constance. The two high-quality buildings were constructed by METHABAU and offer state-of-the-art working conditions for our employees. The...
New Insights into How TPS Enhances Brain Function in Alzheimer’s Mouse Models
A new milestone in TPS research for Alzheimer’s has been achieved! For the first time, scientists have conducted a detailed animal study on healthy and transgenic mice with Alzheimer’s to explore the effects of Transcranial Pulse Stimulation (TPS). This study, a collaborative...
Season’s greetings and a happy new year!
At this special time of year, we want to thank you for the trust you have placed in us. This past year has taken us on an exciting journey, with many challenges but also plenty of successes. It’s with eager expectation...
Transcranial Pulse Stimulation (TPS) – Innovative Therapy for Patients with Alzheimer’s Disease now at the Neurological Rehabilitation Clinic Zihlschlacht
The Rehabilitation Clinic Zihlschlacht in the Swiss canton of Thurgau has been one of the leading centres for neurorehabilitation for over 30 years. Since 1989, the clinic has specialised in supporting patients with neurological conditions through innovative therapy methods and evidence-based...
New study demonstrates the positive biological effects of Extracorporeal Magnetotransduction Therapy (EMTT) on human osteoblasts
A new cell study by Gerdesmeyer et al. reveals for the first time the biological effects of Extracorporeal Magnetotransduction Therapy (EMTT) on primary human osteoblasts (hOBs).1 All processes of osteogenesis – from differentiation to mineralization – are accelerated and upregulated without...
Alzheimer’s disease: new exploratory EEG study evaluates the neurophysiological effect of one TPS session
Transcranial Pulse Stimulation (TPS) uses short, repetitive shock waves with the potential to provide a wide range of vascular, metabolic, and neurotrophic changes. Among the positive features of TPS are good spatial precision in the stimulation of brain regions and the...
The product innovations MASTERPULS® ultra+ and MAGNETOLITH® ultra+ cause a stir at Rééduca and REHACARE International 2024
STORZ MEDICAL presented two new devices at the trade fairs Rééduca in Paris and REHACARE International in Düsseldorf in September 2024: the new radial ESWT entry-level device, MASTERPULS® ultra+, and the EMTT innovation, MAGNETOLITH® ultra+. These technologies, based on Extracorporeal Shock...
Supercharge your tissue – The new MAGNETOLITH® ultra+
Extracorporeal Magnetotransduction Therapy (EMTT) with the new MAGNETOLITH® ultra+ is based on advanced technology, which uses high-energy magnetic pulses for non-invasive treatment of chronic musculoskeletal conditions such as lower back pain, tendinopathies and osteoarthritis. Thanks to its patient-friendly, exceptionally easy handling,...
Grand Opening of STORZ MEDICAL Japan
In August 2024, STORZ MEDICAL proudly celebrates the grand opening of its subsidiary in Japan. Established in February 2024, STORZ MEDICAL Japan Co., Ltd. (ストルツメディカル・ジャパン株式会社) comprises a dedicated team of 18 professionals who specialize in the sales and maintenance of STORZ...
MASTERPULS® ultra+ – The new radial starter model from the »ultra« line
The new radial MASTERPULS® ultra+ shock wave device expands the product portfolio of the successful MASTERPULS® »ultra« line. It is perfect for entering the arena of radial shock wave therapy and combines advanced technology with high reliability. The integrated touch screen...